Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-21-030742

Director acquired 2,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Postma Robert W Director 2021-03-04 Grant or award +2,500 1,181,362 D
Derivatives
Postma Robert W Director 2021-03-04 Grant or award · Stock Option (right to buy) +18,750 18,750 D
Postma Robert W Director 2021-03-04 Grant or award · Stock Option (right to buy) +150,000 150,000 D
Loading xslF345X03/doc4.xml…